ArticleEuropean archives of psychiatry and clinical neuroscience2020

A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.

Christian Schmidt-Kraepelin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.